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Abstract: Quantification of skin changes due to acanthosis nigricans (AN), 
a disorder common among insulin-resistant diabetic and obese individuals, 
was  investigated  using  two  optical  techniques:  diffuse  reflectance 
spectroscopy  (DRS)  and  colorimetry.  Measurements  were  obtained  from 
AN  lesions  on  the  neck  and  two  control  sites  of  eight  AN  patients.  A 
principal  component/discriminant  function  analysis  successfully 
differentiated between AN lesion and normal skin with 87.7% sensitivity 
and  94.8%  specificity  in  DRS  measurements  and  97.2%  sensitivity  and 
96.4% specificity in colorimetry measurements. 
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1. Introduction 
Obesity is one of the major health problems in the USA. According to one overweight and 
obesity prevalence estimation, over two thirds of American adults are overweight and over 
one third of adults are obese [1]. Among insulin-resistant diabetic patients who also suffer 
from obesity, acanthosis nigricans (AN) is a very common associated skin disorder causing 
skin darkening and roughening mostly occurring in the posterior and lateral folds of the neck, 
the axilla, inframammary, groin, and other areas. However, the exact relationship between 
insulin, obesity, and insulin resistance of diabetic patients is not yet fully understood [2]. 
Acanthosis nigricans can occur due to several other conditions such as a result of glandular 
disorder, Addison disease (deficiency of hormones from the adrenal gland), disorder from the 
pituitary gland, low level of thyroid hormones, and oral contraceptives. However, obesity 
remains  the  major  cause  [3].  Acanthosis  nigricans  is  typically  diagnosed  visually  by  a 
dermatologist  or  other  physician.  An  all-optical  transdermal  diagnostic  based  on  light 
scattering that could assist in the diagnosis of acanthosis nigricans and quantitatively monitor 
changes  in  skin  darkening  and  thickening  would  be  extremely  useful  for  diagnosis  and 
assessing compliance to therapy. 
Skin’s  surface  structure,  chromophore  composition,  and  compositional  variation  with 
depth can strongly influence the characteristic features of a spectrum of light scattered from a 
skin  sample.  When  light  is  incident  on  a  sample  reflection,  scattering,  absorption,  and 
transmission through the sample can occur. In simple media, the reflection of light obeys the 
law  of  reflection  and  the  transmission  of  light  obeys  Snell’s  law.  The  Fresnel  equations 
describe reflection and transmission of light through multiple media having different indices 
[4]. 
Reflection can be defined as either specular or diffuse. Specular reflection is the reflection 
off of smooth or glossy surfaces in which an incoming ray is reflected into a single outgoing 
direction obeying the law of reflection. Conversely, when parallel rays of light are incident on 
a  rough  surface,  the  direction  of  the  reflected  light  rays  may  differ  due  to  different 
orientations of the surface normals for the various incident rays. As well, once the light enters 
into the skin multiple scattering can occur internally due to the different components present 
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orientations. This type of non-specular reflection is called diffuse reflection. 
Many  theoretical  models  have  been  developed  to  describe  the  diffuse  reflectance 
phenomenon. The model proposed by Farrell et al. in 1992 [5] is quite successful. This model 
allows a determination of tissue optical properties from diffuse reflectance spectra, using only 
the shape of the reflectance curve. This model was improved by Zonios et al. in 1999 [6] and 
was  applied  to  biological  tissues  by  introducing  four  main  parameters:  hemoglobin 
concentration, hemoglobin saturation, effective scatterer density, and effective scatterer size 
of  the  tissue.  Hemoglobin  and  melanin  are  the  main  chromophore  absorbers  in  the  skin. 
Absorption (scattering) can be explained using the characteristic parameter called absorption 
(scattering)  coefficient  μa  (μs)  which  is  defined  as  the  probability  of  photon  absorption 
(scattering) per unit path length in a medium. This coefficient depends on the cross section 
and the number density of the absorbers (scatterers) [7]. Since hemoglobin can be either in the 
form of oxyhemoglobin or deoxyhemoglobin, their concentrations can be estimated using the 
known absorption coefficients of biological tissues at different wavelengths. Subsequently, 
quantitative assessment of human skin melanin, hemoglobin, and light scattering properties 
were determined using diffuse reflectance spectroscopy in the visible and near-infrared ranges 
based on the same analytical model [8]. Since all these experiments were done using fiber 
optic  probes,  attempts  to  design  a  ball  lens  coupled  fiber  optic  probe  for  depth  resolved 
spectroscopy  of  epithelial  tissues  were  also  reported  [9,10].  Katika  et  al.  in  2006  [11] 
investigated optical properties of human skin using steady state directional diffuse reflectance 
through numerical simulations using a seven-layer skin model. Diffuse reflectance spectra of 
warts, vitiligo, thrombus, and angioma were analyzed using principal component analytical 
methods and were able to differentiate and characterize these skin conditions [12]. 
A chromameter (used for colorimetry) is a type of spectrophotometer which can be used 
for  complex  color  analysis  with  high  precision  and  can  accurately  determine  the  spectral 
reflectance at each wavelength [13]. Several studies have reported the quantification of skin 
color and pigmentation using a colorimeter [14–16]. Different skin areas of healthy adults 
were tested using three colorimeters; a chromameter, a dermaspectrometer, and a mexameter 
were able to quantify small skin color changes [14] including erythema, darkening and skin 
blanching. The intensity of erythema [15], reaction of physical and allergic stimuli, effect of 
depigmentation of sunscreen, and bleaching agents have been reported [16]. 
No studies had directly compared colorimetry and diffuse reflectance spectroscopy (DRS) 
as  applied  to  the  same  patient  group  in  a  clinical  application  prior  to  our  2010  work  to 
investigate the usefulness of these two techniques for the diagnosis of AN. In our previous 
study, we concluded that the darkness of the skin as determined by colorimetry is a reliable 
indicator of AN relative to normal skin and is more efficacious than the concentration of 
melanin as determined by DRS [17]. No conclusion about the ability of these techniques to 
discriminate AN lesion from non-AN lesion darkened skin (i.e. due to tanning) was drawn. In 
this paper, we utilize a chemometric approach to analyze the data obtained from these AN 
patients  by  colorimetry  and  DRS  to  evaluate  whether  a  classification  of  “lesion”  skin  or 
“healthy” skin can be made more reliably using a chemometric model which utilizes more of 
the  data  at  one  time  compared  to  a  straight-forward  calculation  of  a  skin  chromophore 
concentration or the use of individual color parameters (e.g.  melanin concentration or L* 
value related to skin darkness). 
Another important aspect of the chemometric analysis of the DRS data is its use of only 
the raw diffuse reflectance (or absorbance) spectra instead of a reliance on calculated model-
dependent  melanin, oxyhemoglobin, and deoxyhemoglobin chromophore concentrations to 
differentiate normal healthy skin from AN lesion. The scattering of light from a medium as 
heterogeneous as skin is a complex phenomenon, and thus any model of this scattering is at 
best an approximation. Moreover, there were also limitations with using this DRS system for 
measurement of AN lesions since the original algorithm was designed to evaluate smooth 
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model and the calculation of any chromophore concentration. 
2. Materials and Methods 
2.1. Spectroscopy 
The DRS apparatus consisted of a HL-2000 Ocean Optics deuterium tungsten halogen lamp 
for skin illumination, a broadband spectrophotometer (USB 2000 light detector; BWTEK, 
Inc., USA) capable of detecting absorbance in the wavelength range 350-850 nm, a bifurcated 
fiber optic probe for light delivery and scattered light collection, and a computer. The output 
end of the bifurcated fiber bundle which was placed in contact with the skin was 2.5 mm. The 
absorbance spectra were calculated from the measured scattered light spectrum by a custom 
Labview v 8.0 (Labview Inc.) program (Johnson and Johnson, NJ, USA). 
The colorimeter apparatus consisted of a CM-2600d spectrophotometer (Konica Minolta 
CM-2600d,  Osaka,  Japan)  which  utilized  a  Xenon  arc  lamp  for  skin  illumination  and  a 
computer. Scattered light is collected by the CM-2600d through an integrating sphere whose 
internal surface is coated with a barium sulfate coating to make the light diffuse uniformly 
[13]. This instrument uses the standard tristimulus color analysis method utilizing the L*a*b* 
color  system.  The  numerical  parameters  L*,  a*,  and  b*  represent,  respectively,  a  color’s 
darkness  to  lightness,  its  green  to  red  color  component,  and  its  blue  to  yellow  color 
component. A circular patch of skin 8 mm in diameter was illuminated by the CM-2600d 
instrument. Both instruments were corrected for detector dark current and calibrated with a 
standard white disk prior to measurements on every patient. These instruments are shown in 
Fig. 1. 
2.2. Data collection 
DRS and colorimetry measurements were obtained from four areas on the individual patient; 
two considered to be healthy tissue and used as a control and two areas of an acanthosis 
nigricans  lesion  on  the  neck  (Fig.  1).  The  two  control  sites  were  the  inner  forearm 
approximately 10 cm from the wrist and the flat part of the upper shoulder several inches 
from the neck on the clavicle. Spectra from the AN lesion were collected from the median and 
lateral  areas  of  neck.  DRS  and  colorimetry  data  were  collected  from  eight  patients  with 
acanthosis nigricans over an eight month period. Three colorimetry and ten DRS absorbance 
spectra measurements were taken from each site. The higher number of DRS measurements 
was necessary due to the smaller area of tissue sampled by the smaller DRS probe area. Since 
the probing pressure of the human skin can change the diffuse reflectance spectra [18], care 
was  taken  to  insure  uniform  pressure  on  the  skin  over  the  course  of  the  study.  All 
measurements were taken at the same room temperature and humidity. For documentation and 
comparison, photographs of the lesion area were also taken every visit using a digital camera 
with a cross-polarized filter. 
2.3. Chemometric techniques 
In our previous study, differences between the lesion and healthy skin were determined by 
calculating  average  values  of  L*,  a*,  b*,  melanin  concentration,  oxyhemoglobin 
concentration, and deoxyhemoglobin concentration, calculating the standard deviation of the 
measurements, and determining the average difference between healthy and lesion tissue [17]. 
Average values that differed by more than 3 standard deviations (3-sigma) were considered to 
be  valuable  predictors  of  the  presence  of  lesion  tissue.  In  this  work,  colorimetry  data 
consisting of the L*, a*, and b* values and the raw absorption spectra of skin were analyzed 
separately using two chemometric methods known as principal component analysis (PCA) 
and discriminant function analysis (DFA). 
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Fig. 1. Left (top to bottom): DRS setup with laptop, spectrophotometer, halogen light source, 
calibration plate and bifurcated fiber optic cable; close-up of DRS probe showing 2 mm fiber 
optic core; DRS probe applied to patient’s posterior neck; Right (top to bottom): colorimeter; 
close-up of colorimeter 8 mm aperture; colorimeter measuring patient’s posterior neck. 
PCA is a statistical method which correlates all the n variables of a data set and then 
determines which variables carry the most significant information in the data set. Thus, the 
original data set is transformed into a new data set having a reduced number of variables that 
carry the maximum variance in the data set [12]. In the PCA of the DRS data, the entire 
broadband DRS spectrum (226 channels spanning 450 nm with a 2 nm channel width) was 
used as an input data set. The PCA reduced the 226 variables to 4 variables which captured 
99.7% of the variance in the data. These new variables were then used as the input to the 
DFA. The colorimetry data, consisting of only 3 parameters or variables (L*, a*, and b*) were 
not  analyzed  with  a  PCA.  The  raw  spectra  were  not  obtainable  from  the  CM-2600d 
instrument. 
The DFA method classifies the data into the independent groups present in the data by 
minimizing  the  variations  within  the  groups  and  maximizing  the  variations  between  the 
groups  [19].  The  DFA  constructs  N-1  discriminant  functions  (DFs)  for  discrimination 
amongst N user-defined groups. Each spectrum can then be classified by N-1 DF scores. The 
DF scores  were then used to allow a classification of an unknown sample as “lesion” or 
“healthy”. Typically each data set possessed only two DF scores, as we were attempting to 
differentiate between only three user-defined groups: control (forearm), control (neck), and 
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analysis  showed  no  difference  in  these  measurements  and  no  utility  in  separating  these 
measurements. Therefore all these lesion measurements were combined in the analysis. 
To lessen the between-patient scatter of the measurements due to the inherent differences 
in skin coloring and composition of the patients, prior to analysis both colorimetry data and 
DRS data were normalized for every patient. This was done by first calculating the average of 
the patient’s forearm control measurements. The scatter of the forearm control measurements 
about  this  average  allowed  us  to  characterize  the  anticipated  scatter  of  the  lesion 
measurements which was expected to be even greater due to the heterogeneity of the lesion 
tissue.  All  subsequent  measurements  were  then  divided  by  that  patient’s  average  forearm 
control to insure that data obtained from the neck control or neck lesion tissue were really 
differences from that patient’s normal skin coloring or composition. 
3. Results and Discussion 
The mean DRS absorbance spectra of the three measurement sites for one patient are shown 
in Fig. 2. Absorbance is a unitless quantity obtained from the diffuse reflectance spectrum 
[20]. Each of the three spectra shown in Fig. 2 is the average of the all the measurements 
made at that particular site. 
 
Fig. 2. Mean absorbance spectra of forearm control, neck control, and lesion. Lesion tissue 
demonstrates significantly greater absorption/weaker scattering. 
Regions of large absorbance indicate strong absorption or weak scattering of the light at 
that wavelength, sometimes indicative of the presence of a specific chromophore. In Fig. 2 a 
clear increase in the absorbance of the lesion can be seen compared to the controls (forearm 
and neck). This is indicative of an increase in the concentration of the chromophores melanin, 
oxyhemoglobin,  and  deoxyhemoglobin,  as  was  shown  in  our  previous  analysis  of  these 
patients.  Aside  from  this  overall  increase  in  absorbance,  statistically  meaningful  and 
reproducible spectral differences are hard to quantify in the three spectra shown in Fig. 2. 
Chemometric techniques provided a more reliable way to obtain quantitative classification 
of the differences in the spectra. Figure 3 shows the first two discriminant function scores of 
the DFA performed on (a) the normalized DRS data (subject to PCA first, as explained above) 
and (b) the colorimetry data obtained from all eight patients spanning all patient visits. In the 
DFA results, DF1 expresses the maximum variance of the data and DF2 contains the rest of 
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measurements, the center of mass of the lesion data distribution (shown as the dark square in 
Fig. 3) is well separated from the centers of mass of the distribution for the two controls. The 
reversal of the DF1 scores for the two modalities (i.e. positive DF1 lesion scores for DRS and 
negative  DF1  scores  for  colorimetry)  has  no  physical  significance  and  is  purely  a 
computational  artifact.  The  fact  that  all  the  patients’  data  can  be  clustered  significantly 
implies that the variations of the lesion tissue from the control sites are reproducible and 
similar in all patients. 
 
Fig. 3. Discriminant function plots for (a) DRS and (b) colorimetry data obtained from all 
patients over the course of this study. 
A leave-one-out (LOO) classification was also performed for both data sets. In a LOO 
method, each data point is treated as an unknown case and is classified against a data set 
consisting of all the other data points. The accuracy of that classification is then compared to 
the known identity of the data point to create a truth table. The truth tables for both spectral 
methods are shown in Table 1. The interpretation of these truth tables is as follows: true 
positives (TP) indicate a lesion measurement was correctly classified as lesion. True negatives 
(TN)  indicate  a  normal  control  measurement  was  correctly  classified  as  normal.  False 
positives (FP) indicate a normal control measurement was incorrectly classified as lesion. 
False negatives (FN) indicate a lesion measurement was incorrectly classified as normal. 
Colorimetry data showed the highest true positive and true negative results, 98.4% and 
96.1% respectively, which confirmed our earlier result that colorimetry seems to be more 
efficacious for diagnosing AN than DRS as we currently perform it [17]. Impressively, when 
analyzed with the PCA/DFA the DRS data showed more than 91% sensitivity (TP/TP + FN) 
and specificity (TN/TN + FP), which was not the case for the standard statistical analyses as 
we have reported earlier [17]. 
Table 1. Truth tables for leave-one-out classification results of DRS and colorimetry. 
DRS (%)    Colorimetry (%) 
   True  False       True  False 
Positive  91.4  4.9    Positive  98.4  3.9 
Negative  95.1  8.6    Negative  96.1  1.6 
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set of discriminant functions constructed using all the other data points, including other data 
points from that same patient. However, if either of these techniques is to be used for patient 
screening, it is not realistic to expect the discriminant functions to have been constructed with 
any prior data from that patient. Therefore we performed a DFA excluding one patient at a 
time from the analysis. Unclassified lesion and neck control data from that patient were then 
input to the DFA (which contained none of that patient’s other data) and were classified 
according to the library of results from other patients. The truth tables for this analysis are 
shown in Table 2. As expected the rates of true positives and true negatives declined, although 
only by a small amount (by 3.7% and 0.3% for DRS and 1.2% and 1.5% for colorimetry) and 
rates of false positives and false negatives increased (by 0.4% and 3.7% for DRS and 1.5% 
and 1.2% for colorimetry). These results show a more realistic truth table for the techniques if 
they were to be used to screen previously unexamined patients for AN. 
Table 2. Truth tables for patient exclusion classification results of DRS and colorimetry. 
DRS (%)    Colorimetry (%) 
   True  False       True  False 
Positive  87.7  5.2    Positive  97.2  5.4 
Negative  94.8  12.3    Negative  94.6  2.8 
One of the benefits of using a chemometric approach is shown in Fig. 4 which shows the 
DF plot of the patient exclusion analysis for patient 8 in our previous study. Patient 8 was the 
only case in our previous study that did not show a 3-sigma standard deviation between the 
calculated melanin concentration in the forearm control and the AN lesion indicating that this 
patient’s lesion tissue was very hard to diagnose spectrally [17]. Nonetheless, in Fig. 4, when 
patient 8’s lesion data was entered as unclassified data into the DFA (shown as golden x 
symbols  in  Fig.  4),  almost  all  of  the  measurements  were  easily  classified  as  “lesion” 
compared to the forearm control or the neck control. 
The higher diagnostic accuracy of the colorimetry technique as shown in Tables 1 and 2 
seems counter-intuitive since the DRS spectral data contains more diagnostic information than 
the colorimetry data which are calculated from measurements of narrow spectral ranges. The 
results  obtained  are  due  to  the  inherent  differences  in  the  reliability/repeatability  of  the 
measurements made by these two instruments, specifically differences resulting from probe 
design.  The  DRS  probe  not  only  collected  light  from  a  much  smaller  skin  area  than  the 
colorimeter (a diameter of 2.5 mm compared to 8 mm), but also from a much smaller solid 
angle  compared  to  the  integrating  sphere  of  the  colorimeter.  This  resulted  in  increased 
measurement  scatter.  To  prove  this,  the  repeatability  of  both  instruments  was  tested  by 
making repeated measurements twice daily for 5 days on a standard target consisting of a 
section of a skin prosthesis. The results of these measurements indicated that the percent 
deviation of the DRS measurements was inherently higher than the colorimetry measurements 
due  to  the  smaller  light  collection  area  and  solid  angle  of  the  DRS  probe  which  made 
measurements made with it more sensitive to inhomogeneities of the skin prosthesis. 
Although forearm and neck controls were both used as normal controls in this AN study, 
the more realistic site for a normal control is the neck normal (which should have similar 
properties compared to the lesion measurement site due to tanning, aging, etc). This can be 
observed by the neck control data being closer to the lesion data than the forearm control data 
in Figs. 3 and 4. Thus, it was vital to know the sensitivity and specificity of the lesion site 
measurements  as  compared  to  the  neck  control.  To  investigate  this,  receiver  operating 
characteristic  (ROC)  curves  were  constructed  using  the  DF1  values  of  the  DRS  and 
colorimetry  data  to  act  as  a  “cut  point”  to  discriminate  lesion  and  neck  control  data 
(discarding the forearm control data). 
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Fig. 4. DF plots showing (a) DRS and (b) colorimetry data with patient 8’s lesion data input as 
unclassified data into the analysis. This patient’s lesion data, which clustered well with itself, 
was significantly different from the mean of the other patients’ lesion data. Nonetheless, it was 
easily and reliably classified as “lesion” in both analyses. 
In a ROC curve [21], the sensitivity of the technique (as defined above) is plotted against 
1-specificity (as defined above). ROC curves are shown in Fig. 5 for DRS (a) and colorimetry 
(b). The ROC area under the curve (AUC) establishes the usefulness of the test, with an AUC 
of 1.0 denoting a perfect test, and an AUC of 0.5 denoting a worthless test. The ROC curves 
of Fig. 5 possess an AUC of more than 0.98, indicating a highly reliable test for this AN 
investigation. 
 
Fig.  5.  ROC  curves  of  a  test  to  differentiate  neck  control  measurements  from  lesion 
measurements (as shown in Fig. 3) on the basis of the DF1 score alone for (a) DRS and (b) 
colorimetry data. The area under the curves for (a) was 0.985 and for (b) was 0.995. 
4. Conclusions 
Spectroscopic and colorimetric measurements combined with chemometric analysis methods 
provided sensitive and specific diagnoses of acanthosis nigricans lesions compared to nearby 
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controls and lesion groups (Fig. 3 (a)) for all patients denoting a commonality that would 
allow diagnoses of previously unmeasured lesions. Colorimetry data also showed the ability 
to reliably identify AN lesions (Fig. 3 (b)). Excluding patients one at a time from a DFA 
model and then testing that patient’s spectral data with the model constructed only from other 
patient measurements provided a realistic simulation of an acanthosis nigricans screening test. 
DRS  data  provided  more  than  87%  sensitivity  and  94%  specificity  and  colorimetry  data 
showed more than 95% sensitivity and specificity (Table 2) in this type of test. ROC curves 
also confirmed that the use of a discriminant function analysis on DRS and colorimetry data 
can provide a sensitive and specific AN test even when only the DF1 score is used to assess 
skin condition. Unfortunately, none of the patients showed any improvement in acanthosis 
nigricans from treatment during the duration of this study which was also confirmed by visual 
and  photographic  observations.  Thus,  the  changes  in  skin  DRS  and  colorimetry  data  that 
occur during the healing process of AN could not be established. However, the existing data 
showed both DRS and colorimetry can be used as a successful diagnostic tool for acanthosis 
nigricans when combined with chemometric methods such as PCA and DFA. 
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